Copperwynd Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $569K | Buy |
|
|||||
|
2025
Q1 | $636K | Buy |
|
|||||
|
2024
Q4 | $513K | Sell |
|
|||||
|
2024
Q3 | $839K | Buy |
|
|||||
|
2024
Q2 | $851K | Buy |
|
|||||
|
2024
Q1 | $725K | Sell |
|
|||||
|
2023
Q4 | $672K | Sell |
|
|||||
|
2023
Q3 | $652K | Sell |
|
|||||
|
2023
Q2 | $590K | Sell |
|
|||||
|
2023
Q1 | $676K | Buy |
|
|||||
|
2022
Q4 | $584K | Sell |
|
|||||
|
2022
Q3 | $568K | Sell |
|
|||||
|
2022
Q2 | $510K | Sell |
|
|||||
|
2022
Q1 | $610K | Buy |
|
|||||
|
2021
Q4 | $446K | Buy |
|
|||||
|
2021
Q3 | $426K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $435K | Buy |
|
|||||
|
2020
Q4 | $300K | Buy |
|
|||||
|
2020
Q3 | $265K | Buy |
|
|||||
|
2020
Q2 | $226K | Buy |
|